20th Anniversary

  • News
  • Inquiry
  • Contact Us for business opportunity
  • Recruitment information
  • Japanese
  • English
  • HOME
  • Vision
    vision
    Introducing the vision of SymBio
    • CEO message
      CEO message
    • SymBio in 2 minutes
      SymBio in 2 minutes
    • Corporate culture
      Corporate culture
    • Charter of Corporate Conduct
      Charter of Corporate Conduct
    • Books
      Books
  • Business model
    Business model
    The following is an introduction to the business model of SymBio.
    • Business domain and profit model
      Business domain and profit model
    • Proprietary drug discovery business
      Proprietary drug discovery business
    • Global business
      Global business
    • Joint research with academia
      Joint research with academia
    • Key person interview
      Key person interview
  • Pipeline
    Pipeline
    SymBio introduces the pipeline of pharmaceuticals.
    • Pipeline overview
      Pipeline overview
    • SyB V-1901
      SyB V-1901
    • SyB L-1701/L-1702
      SyB L-1701/L-1702
      SyB L-0501
      SyB L-0501
  • IR information
    IR information
    Toward a patient-centered, supportive relationship among scientists, doctors, government, and shareholders.
    • Latest IR information
      Latest IR information
    • IR news
      IR news
    • CEO message
      CEO message
    • financial highlights
    • IR library
    • Analyst
      report
    • video library
    • IR Calendar
    • General Meeting of Shareholders Information
    • Basic stock information
    • Electronic public notice
  • About SymBio
    About SymBio
    Company Information of SymBio Pharmaceuticals
    • Company Profile
      Company Profile
    • Origin of company name
      Origin of company name
    • History
      History
    • Officer introduction
    • Organization chart
    • Corporate
      governance
    • compliance
      about
    • on transparency
      Information disclosure
    • SDGs initiatives
  • News
  • Inquiry
  • Contact Us for business opportunity
  • Recruitment information
  • Japanese English
  1. TOP
  2. IR information
  3. Electronic public notice

Electronic public notice

2019.06.10
Public notice regarding consolidation of shares
2016.09.15
Announcement of setting the record date for convening the Extraordinary General Meeting of Shareholders

IR information

  • Latest IR information
  • IR news
  • CEO message
  • financial highlights
  • IR library
  • analyst report
  • video library
  • IR Calendar
  • General Meeting of Shareholders Information
  • Basic stock information
  • Electronic public notice
  • shared research
SymBio Pharmaceuticals Limited SymBio Pharmaceuticals
  • Inquiry
  • Contact Us for business opportunity
  • Personal information protection policy, etc.
  • Privacy Notice for Clinical Trials in UK
  • About the use of the site
  • site map
Copyright © SymBio Pharmaceuticals Limited.